# artesunate/amodiaquine = as/aq

### notes
+ prescription under medical supervision

### therapeutic action
+ antimalarial

### indications
+ treatment of uncomplicated falciparum malaria
+ completion treatment following parenteral therapy for severe falciparum malaria

### presentation
+ co-formulated tablets of artesunate (as)/amodiaquine (aq), in blister packs, for a complete treatment for one individual
+ there are 4 different blister packs corresponding to 4 different categories of weight:
    - 25 mg as/67.5 mg aq base tablet, blister pack of 3 tablets
    - 50 mg as/135 mg aq base tablet, blister pack of 3 tablets
    - 100 mg as/270 mg aq base tablet, blister pack of 3 tablets
    - 100 mg as/270 mg aq base tablet, blister pack of 6 tablets

### dosage and duration
+ tablets are to be taken once daily for 3 days.

| weight        | tablets                                   | d1    | d2    | d3    |
|---------------|-------------------------------------------|-------|-------|-------|
| 4.5 to < 9 kg | 25 mg as/67.5 mg aq                       | 1 tab | 1 tab | 1 tab |
| 9 to < 18 kg  | 50 mg as/135 mg aq                        | 1 tab | 1 tab | 1 tab |
| 18 to < 36 kg | 100 mg as/270 mg aq blister pack of 3 tab | 1 tab | 1 tab | 1 tab |
| ≥ 36 kg       | 100 mg as/270 mg aq blister pack of 6 tab | 2 tab | 2 tab | 2 tab |

### contra-indications, adverse effects, precautions
+ do not administer in the event of previous severe adverse reaction to treatment with amodiaquine (e.g. hypersensitivity reaction, hepatitis, leucopenia, agranulocytosis).
+ do not administer to patients taking efavirenz.
+ may cause: gastrointestinal disturbances, headache, dizziness, pruritus.
+ if the patient vomits within 30 minutes after administration, re-administer the full dose.
+ *pregnancy*: no contra-indication
+ *breast-feeding*: no contra-indication

### remarks
+ storage: below 25°c
+ leave tablets in blisters until use. once a tablet is removed from its blister, it must be administered immediately.